Mouse Integrin alpha V beta 8 (ITGAV&ITGB8) Heterodimer Protein, His Tag&Tag Free

Proteins and Peptides

貨號 Cat. No.
IT8-M52W6
規格 Size
1mg
品牌 Brand
ACROBiosystems
Species
Mouse
Conjugate
Unconjugated
Expression System
HEK293
Tag
His Tag

Description




Source : 


Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (IT8-M52W6) is expressed from human 293 cells (HEK293). It contains AA Phe 31 - Val 988 (ITGAV) & Gly 22 - Leu 681 (ITGB8) (Accession # P43406-1 (ITGAV) & Q0VBD0-1 (ITGB8)).


 

Molecule : Integrin alpha V beta 8


 

Synonyms : Integrin alpha V beta 8,ITGAV&ITGB8


 

Format : Powder


 

Category : Bio-Markers & CD Antigens


 

Accession : NP_032428.2 (ITGAV) & NP_796264.2 (ITGB8)


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 112.5 kDa (ITGAV) & 77.5 kDa (ITGB8)


 

Characteristics :


Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free, produced by co-expression of ITGAV and ITGB8, has a calculated MW of 112.5 kDa (ITGAV) and 77.5 kDa (ITGB8). Subunit ITGAV is fused with an acidic tail at the C-terminus and followed by a polyhistid


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : 50 mM Tris, 150 mM NaCl, pH7.5


 

Description :


Integrin alpha V beta 8 (ITGAV & ITGB8 or ITGAVB8) is expressed in yolk sac, placenta, brain perivascular astrocytes, Schwann cells, renal glomerular mesangial cells and pulmonary epithelial cells. Unlike other alpha V integrins, ITGAVB8 does not appear to assume different activation states, and the cytoplasmic tail does not connect to the cytoskeleton. It binds ligands containing an RGD motif, including vitronectin, fibrin and the latency associated peptide (LAP) of the latent TGF-beta complex. High affinity binding of alpha V beta 8 to LAP allows proteolytic cleavage by MT1-MMP, which releases active TGF-beta. This mechanism differs from that of alpha V beta 6, the other alpha V integrin which can activate TGF-beta from latency through non-proteolytic mechanisms. Downstream effects of TGF-beta activation include control of cell growth and associated vascularization.


 

References :


(1) Moyle, M. et al., 1991, J. Biol. Chem. 266:19650-8.
(2) Nishimura SL., et al., 1994, J Biol Chem. 269(46):28708-15.
(3) Araya, J. et al., 2006, Am. J. Pathol. 169:405-15.
(4) Mu,D.et al.,2002, J. Cell Biol.157:493-507.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢